Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03615703 · ClinicalTrials.gov registry record
Functional MRI Study in Healthy Children Engaged in Aggressive Behaviors
A clinical trial, sponsored by Supernus Pharmaceuticals.
- Completed
- Registry status
- 17
- Enrollment target
NCT03615703: Completed study, sponsored by Supernus Pharmaceuticals.
NCT03615703 is a clinical trial that has completed, run by Supernus Pharmaceuticals. The registered enrollment target is 17 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03615703 has completed, sponsored by Supernus Pharmaceuticals.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
The purpose of this non-interventional study is to optimize the point subtraction aggression paradigms (PSAP) task in typically developing children (TDC).
Primary Outcome
The study has only one visit (approximately 2 hours). During the task each participant competes against a fictitious opponent (a computer in reality) to earn points. The participant will play a computer game in which they can steal points (simulating an aggressive behavior) or have points stolen by the opponent. 10 healthy subjects will be recruited for the study. To make the participant feel comfortable in the MRI, eligible subjects will spend time first to habituate to the scanner and then pr
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2018-08-10 |
| Est. Completion | 2019-03-15 |
What the finished NCT03615703 record still lists
NCT03615703 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03615703 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03615703 about?
NCT03615703 is a clinical study titled "Functional MRI Study in Healthy Children Engaged in Aggressive Behaviors". The purpose of this non-interventional study is to optimize the point subtraction aggression paradigms (PSAP) task in typically developing children (TDC).
What is the current status of trial NCT03615703?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2018-08-10. Estimated completion is 2019-03-15.
Who is sponsoring clinical trial NCT03615703?
This trial is sponsored by Supernus Pharmaceuticals, which has 57 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI